Injectable codeine is readily available for subcutaneous or intramuscular injection only; intravenous injection is contraindicated, as this may result in nonimmune mast-mobile degranulation and resulting anaphylactoid response. Codeine suppositories may also be promoted in certain countries.Expanded Access is a potential pathway for the affected pe